Keywords: عصر; ERA; environmental risk assessment; EMA; European Medicines Agency; OECD; Organisation for Economic Co-operation and Development; EU; European Union; API; active pharmaceutical ingredient; GMO; genetically modified organism; VMP; veterinary medicinal prod
مقالات ISI عصر (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عصر; ERA; endothelin receptor antagonist; IPAH; idiopathic pulmonary arterial hypertension; PAH; pulmonary arterial hypertension; PDE; phosphodiesterase; SC; subcutaneous; 6MWT; 6-minute walk test; Subcutaneous prostanoid; Pediatric treatment; Pulmonary hypert
Keywords: عصر; AAAQ; availability, accessibility, acceptability, quality; ERA; education, regulation, association; HRH; human resources for health; ICM; International Confederation of Midwives; MDG; millennium development goal; MMR; maternal mortality ratio (maternal de
Keywords: عصر; disease progression; GRIPHON; landmark analysis; SERAPHIN; survival; 6MWD; 6-min walk distance; CI; confidence interval; ERA; endothelin receptor antagonist; HR; hazard ratio; PAH; pulmonary arterial hypertension; PDE-5i; phosphodiesterase type-5 inhibito
Keywords: عصر; AmP; Add-my-Pet; DEB; dynamic energy budgets; EFSA; European Food Safety Authority; LD50; lethal dose for 50% of the individuals; LC50; lethal concentration for 50% of the individuals; NOEC; No Observed Effect Concentration; NEC; No Effect Concentration;
Keywords: عصر; ERA; Regulation; Traits; Novel; Epichloë; Alkaloids;
Keywords: عصر; Pulmonary arterial hypertension; Endothelin receptor antagonist; Prostacyclin; Nitric oxide; Dose titration; Specialty pharmacy; ERA; endothelin receptor antagonist; ET-1; endothelin 1; PAH; pulmonary arterial hypertension; PAWP; pulmonary artery wedge pr
Keywords: عصر; Risk assessment model; Risk factors; Factor refinement; CFIA; Canadian Food Inspection Agency; CVS; Compliance Verification System; DALYs; Disability Adjusted Life Years; ERA; Establishment-based Risk Assessment; GFSI; Global Food Safety Initiative; HACCP
Keywords: عصر; BSO; buthionine sulfoximine; DEM; diethyl maleate; ERA; erastin; GCL; glutamate cysteine ligase; GPx; glutathione peroxidase; GR; glutathione reductase; GST; glutathione S-transferase; HCA; homocysteic acid; LOX; lipoxygenase; SSZ; sulfosalazine; Reactive
Keywords: عصر; Emerging pollutants; Occurrence; WWTPs; Estuaries; Passive sampling; Environmental risk assessment; AF; assessment factor; ANOVA; analysis of variance; ARA-II; angiotensin II receptor; CEC; contaminants of emerging concern; DO; dissolved oxygen; EC; effec
Keywords: عصر; Intracranial atherosclerosis; age; sex; pathology; risk factors; era;
Keywords: عصر; congenital heart disease; pulmonary hypertension; hemodynamics; Fontan circulation; AT; anaerobic threshold; CPET; cardiopulmonary exercise testing; ERA; endothelin inhibitor; FVC; forced vital capacity; FEV1; forced expiratory volume in 1Â second; NYHA;
Keywords: عصر; LCA; life cycle assessment; LCI; life cycle inventory; LCIA; life cycle impact assessment; EF; effect factor; CF; characterization factor; BF; bioavailability factor; FF; fate factor; Cu; copper; Ni; nickel; Zn; zinc; TBLM; terrestrial biotic ligand model
Keywords: عصر; Pulmonary hypertension; Pulmonary arterial hypertension; Rho-kinase; Fasudil; CHD; congenital heart diseases; CI; cardiac index; CO; cardiac output; CTD; connective tissue diseases; CTEPH; chronic thromboembolic pulmonary hypertension; ERA; endothelin rec
Keywords: عصر; behavioural syndrome; boldness; ERA; esfenvalerate; personality; repeatability; urbanization;
Keywords: عصر; Eisenmenger syndrome; Drug therapy; Outcome; Pulmonary arterial hypertension; Congenital heart diseases; Syndrome d'Eisenmenger; Médicament; Pronostic; Cardiopathies congénitales; Hypertension artérielle pulmonaire; CHD; Congenital heart disease; ERA
Keywords: عصر; ALS; Acetolactate Synthase; bp; Base pairs; Bt; Bacillus thuringiensis; CaMV; Cauliflower Mosaic virus; DNA; Deoxyribonucleic Acid; EFSA; European Food Safety Authority; EPA; Environmental Protection Agency; ERA; Environmental Risk Assessment; FSA; Farm S
Keywords: عصر; comparative efficacy; network meta-analysis; pulmonary arterial hypertension; 6MWD; 6-min walk distance; ERA; endothelin receptor antagonist; FDA; Food and Drug Administration; GRADE; Grading of Recommendations Assessment, Development, and Education; NYHA
Keywords: عصر; PGA; physician's global assessment; PGE; parental global evaluation; ESR; erythrocyte sedimentation rate; JADAS; Juvenile Arthritis Disease Activity Score; cJADAS; clinical JADAS; PICO; Patient Intervention Comparison Outcome; JRA; juvenile rheumatoid a
Simultaneous quantification of endothelin receptor antagonists and phosphodiesterase 5 inhibitors currently used in pulmonary arterial hypertension
Keywords: عصر; ERA; endothelin receptor antagonist; LC-MS/MS; high performance liquid chromatography coupled to tandem mass spectrometry; PAH; pulmonary arterial hypertension; PDE5I; phosphodiesterase 5 inhibitor; SPE; solid phase extraction; EMA; European Medicines A
Keywords: عصر; ZEP; zero equivalent point; Ymax; maximal stimulatory effect; ERA; environmental risk assessment; dXZâN; the width of the hormetic zone; HorAreaR; relative standard area of the hormetic zone; HorAreaA; absolute area of the hormetic zone; CA; concentrati
Keywords: عصر; GM maize; GM potato; European biogeographical regions; ERA; EFSA Guidance Document; Focal species;
Keywords: عصر; age; outcomes; pulmonary arterial hypertension; pulmonary hypertension; 6MWD; 6-min walk distance; COMPERA; Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension; CTD; connective tissue disease; ERA; endothelin receptor
Keywords: عصر; heart failure with preserved ejection fraction; idiopathic pulmonary arterial hypertension; ERA; endothelin receptor antagonist; HFpEF; heart failure with preserved ejection fraction; IPAH; idiopathic pulmonary arterial hypertension; PAPm; mean pulmonary
Keywords: عصر; BAS; biocidal active substance; BP; biocidal products; ERA; environmental risk assessment; BPR; EU Biocidal Products Regulation 528/2012; PCP; personal care products; PPP; plant protection products; PT; product type; STP; sewage treatment plants; WCA; was
Keywords: عصر; Citation analysis; Peer review; Source normalized impact per paper; Raw impact per paper; Journal impact factor; ERA;
Keywords: عصر; APIs; Active Pharmaceutical Ingredients; AD; applicability domain; ATI; Aquatic Toxicity Index; PBT; Persistence, Bioaccumulation and Toxicity; CAS; Chemical Abstract Service; CCC; concordance correlation coefficient; CEC; Contaminants of Emerging Concern
Keywords: عصر; ACE; acenaphthene; ACY; acenaphthylene; ADD; average daily dose; ANT; anthracene; AT; averaging time; BAA; benzo(a)anthracene; BAP; benzo(a)pyrene; BAPeq; BAP equivalent concentration; BBF; benzo(b)fluoranthene; BGHI; benzo(ghi)perylene; BKF; benzo(k)fluo
Keywords: عصر; A; Acetone extract; AAE; Water-acetone extract; AC; Alliun cepa; ACE; Acetate extract; AE; Aqueous extract; AEE; Hydroalcoholic extract; AI; Apoptosis-inducing; Ames; Bacterial reverse mutation assay; AN; Aspergillus nidulans; ANVISA; Agência Nacional
Keywords: عصر; Bosentan; Perfluorinated analogues; Metabolic specificity; Phase I metabolism; HLM; Cl; Clearance; CYP; Cytochrome P450; DDI; drug-drug interactions; ERA; Endothelin Receptor Antagonist; ET-1; Endothelin 1; ETA; Endothelin receptor A; ETB; Endothelin rece
Keywords: عصر; Rabies virus; Preservation by vaporization; Stability; Efficacy; Immunogenicity; ECL; electrochemiluminescent; ERA; Evelyn-Rokitnicki-Abelseth; ffu; focus forming units; GMT; geometric mean titer; G; glycoprotein; IM; intramuscular; IU; international
Keywords: عصر; Education; Science; Learning; New; Era
Keywords: عصر; Endothelin receptor antagonist; Pulmonary arterial hypertension; Fetal development; Pulmonary vasculature; ERA; PAH; ET-1; Fetal gene program;
Keywords: عصر; EQS; environmental quality standard; LOEC; lowest observed effect concentration; ERA; environmental risk assessment; Diclofenac; Pharmaceuticals; Environmental risks; Ecotoxicity; Freshwater ecosystems; Environmental policies;
Keywords: عصر; API; Active pharmaceutical ingredient; BOD5; Biochemical oxygen demand in 5 days; EC50; 50% effect concentration; ERA; Environmental risk assessment; EU; European Union; NA; Not available; NOEC; No observed effect concentration; NRT; New Roche test; OECD;
Keywords: عصر; 6WMD; 6-min walk distance; 6MWT; 6-min walk test; cGMP; cyclic guanosine monophosphate; CTD; connective tissue disease; ERA; endothelin receptor antagonist; ET-1; endothelin-1; HRQoL; health-related quality of life; MCS; mental component summary; MID; min
Keywords: عصر; AgNM; silver nanomaterials; AF; assessment factor; dw; dry weight; EC10; effect concentration at which 10% of the test population are affected; EC50; effect concentration at which 50% of the test population are affected; ERA; environmental risk assessment
Keywords: عصر; âHf; heat of formation; AFVs; armour fighting vehicles; AP; ammonium nitrate; APFSDS; armour piercing fin stabilised discarding sabot; ATEC; acetyl triethyl citrate; C/M ratio; charge to mass ratio; CAB; cellulose acetate butyrate; CL-20; 2,4,6,8,10,12-
Keywords: عصر; AAF; analgesics and anti-inflammatory; ABI; antibiotic; AF; assessment factor; AEMPS; Spanish Agency for Medicines and Medical Devices; API; active pharmaceutical ingredient; BBL; β-Blocker; CAS; chemical abstracts service; DDD; defined daily dose; DIU;
Keywords: عصر; GnRH neurons; Kisspeptin neurons; Female puberty; Chromatin modifications; DNA methylation; Transcriptional repression; Transcriptional activation; Epigenetic regulators; microRNAs; Long noncoding RNAs; 5hmC; 5-hydroxymethylcytosine; 5-mC; 5-methylcytosin
Keywords: عصر; AMX; amoxicillin; AOZ; 3-amino-2-oxazolidinone; APCI; atmospheric pressure chemical ionization; ASV; anodic stripping voltammetry; BCF; bioconcentration factor; BI; bead injection; CE; capillary electrophoresis; CID; collision induced dissociation; CFUF;
Keywords: عصر; BBC; Bâtiment Basse Consommation; BREEAM; Building Research Establishment Environmental Assessment Methodology; BMS; Building energy Management Systems; CFL; Compact Fluorescent Light; DGNB; Deutsche Gesellschaft für Nachhaltiges Bauen e.V.; EPBD; Energ
Keywords: عصر; ERA; Risk assessment; EPAR; European Medicines Agency; Marketing authorisation;
Keywords: عصر; ADD; average daily dose; COPC; contaminant of potential concern; CR; concentration ratio; EA; environmental assessment; EFW; energy-from-waste; EHQ; environmental hazard quotient; EPC; exposure point concentration; ERA; environmental risk assessment; HHRA
Keywords: عصر; ERA; European science policy; Role of scientific organisations; European Research Council; H2020; Health, Demographic Change and Well-Being Societal Challenge; Scientific Panel for Health;
Keywords: عصر; a; aerobic stabilization; 6ACM; 6-acetylmorphine; ADI; acceptable daily intake; AF; assessment factor; ALP; alprazolam; AM; amphetamine; ATS; amphetamine-type stimulant; BAS; biologic-activated sludge; BB; bacterial bed; BE; benzoylecgonine; bf; belt-filt
Keywords: عصر; EFSA; European Food Safety Authority; ERA; environmental risk assessment; EU; European Union; GM; genetically modified; GMO; genetically modified organism; HR; herbicide resistant; IOBC; International Organization for Biological Control; IR; insect resist
Keywords: عصر; EC; European commission; EDQM; European directorate for the quality of medicines & healthcare; ERA; Evelyn Rokitnicki Abelseth; G; glycoprotein; M; matrix; N; nucleoprotein; P; phosphoprotein; OIE; World Organization for Animal Health; ORV; oral rabies va
Keywords: عصر; AC; Acidification; AD; Abiotic Depletion; CLCA; Consequential Life cycle assessment; EEPCo; Ethiopian Electric Power Corporation; EHPEA; Ethiopian Horticulture Producer Exporters Association; EHPEACoP; Ethiopian Horticulture Producer Exporters Association
Keywords: عصر; Railways; Safety; Accidents; Cost benefit analysis; Train protection; Level crossings; Privatisation; Deregulation; ALCRM; All Level Crossing Risk Model; ATP; Automatic Train Protection; BCR; Benefit cost ratio; BR; British Rail or British Railways; CBA;